바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 연세암병원-종양내과, 대장암센터, 비뇨기암센터

전문진료분야

  • <종양내과> 대장암, 흑색종, 비뇨기암, 항암약물치료, 신약치료

진료시간표

인터넷진료예약
의사시간표
진료시간
오전 암병원 암병원 암병원
오후 암병원

교육 및 임상 경력

  • 1998.3-1999.2:  서울  아산병원  인턴
  • 2002.5-2006.2:  영남대학  병원  전공의(내과)
  • 2006.3-2008.2:  연세대  의대  내과학교실  연구강사
  • 2008.3-2009.2:  연세대  의대  내과학  교실  전임강사
  • 2009.3-2013.2:  연세대  의대  내과학  교실  조교수
  • 2012.3-2014.2:  미국  MD  Anderson  Cancer  Center  연수
  • 2013.3-현재    :  연세대  의대  내과학  교실  부교수

학술관련경력

  • 대한내과학회
  • 대한암학회
  • 대한종양내과학회
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • European Society for Medical Oncology

주요 관심분야

  • 대장암 (소화기암)의 항암약물치료
  • 흑색종 치료

학력사항

  • 1998 영남대학교 의과대학 학사
  • 2005 영남대학교 의과대학 석사
  • 2011 연세대학교 의과대학 박사

논문

  • Kim SH, Cho BC, Choi HJ, Chung KY, Kim DJ, Park MS, Kim SK, Chang J, Shin SJ et al: The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. Lung Cancer Dec 21, 2007
  • Choi HJ, Cho BC, Shin SJ, et al: Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Cancer Chemother Pharmacol 61:309-13, 2008
  • Cho BC, Im CK, Park MS, Kim SK, Chang J, Park JP, Choi HJ, Kim YJ, Shin SJ et al: Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib, J Clin Oncol, 2007, 2528-33
  • Jeung HC, Rha SY, Shin SJ, et al: A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status. Br J Cancer 97:458-63, 2007
  • Shin SJ, Jeung HC, Ahn JB, et al: Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. Cancer Chemother Pharmacol, 2007
  • Sohn JH, Choi HJ, Chang J, Shin SJ et al: A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer. Lung Cancer 54:365-70, 2006
  • Lee KH, Shin SJ, Kim KO, et al: Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep 16:823-30, 2006
  • Kim KO, Lee HY, Chun SH, Shin SJ et al: Clinical overview of extrapulmonary small cell carcinoma. J Korean Med Sci 21:833-7, 2006
  • Shin SJ, Kim KO, Kim MK, et al: Expression of E-cadherin and uPA and their association with the prognosis of pancreatic cancer. Jpn J Clin Oncol 35:342-8, 2005
  • Shin SJ, Chun SH, Kim KO, et al: Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenstrom's acroglobulinemia after sequential treatment with chlorambucil and fludarabine. Jpn J Clin Oncol 35:622-5, 2005
  • Shin SJ, Chun SH, Kim KO, et al: The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: a multicenter phase II study. Korean J Intern Med 20:135-40, 2005
  • Shin SJ, Kim MK, Lee KH, Hyun MS,Bae SH, Ryoo HM, et al: The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-FU based Chemotherapy: a Single-Center Phase II Study. Cancer Research and Treatment, 2004
  • Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients
    FRONTIERS IN ONCOLOGY 9/ :835-,2019
  • Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
    FRONTIERS IN ONCOLOGY 9/Issue J :Article number 529-,2019
  • Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
    Journal of Cancer Prevention 24/1 :48-53,2019
  • The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY 48/11 :988-994,2018
  • CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
    YONSEI MEDICAL JOURNAL 59/5 :588-594,2018
  • IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors
    CANCER IMMUNOLOGY RESEARCH 6/6 :685-695,2018
  • Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
    CANCER RESEARCH 78/18 :5,315-5,326,2018
  • Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma
    CANCER RESEARCH AND TREATMENT 50/4 :1238-1251,2018
  • Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
    CANCER RESEARCH AND TREATMENT 50/4 :1,378-1,387,2018
  • Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection
    CLINICAL COLORECTAL CANCER 17/3 :513-518,2018
  • Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 144/6 :1119-1128,2018
  • YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
    CANCER IMMUNOLOGY RESEARCH 6/3 :255-266,2018
  • A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors
    INVESTIGATIONAL NEW DRUGS 35/6 :773-781,2017
  • Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    ONCOGENE 36/23 :3,334-3,345,2017
  • IL-21-mediated reversal of NK cell exhaustion facilitates anti-Tumour immunity in MHC class I-deficient tumours
    NATURE COMMUNICATIONS 8/15776 :1-14,2017
  • Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
    BMC CANCER 17/615 :615-625,2017
  • Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid?upper rectal cancer
    JOURNAL OF RADIATION RESEARCH 58/4 :559-566,2017
  • Quality of life among Korean gastrointestinal cancer survivors
    EUROPEAN JOURNAL OF ONCOLOGY NURSING 30/ :15-21,2017
  • Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
    ONCOLOGY LETTERS 14/2 :2,385-2,392,2017
  • Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer
    ANNALS OF SURGICAL ONCOLOGY 24/1 :227-235,2017
  • Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
    AMERICAN JOURNAL OF CANCER RESEARCH 7/1 :134-138,2017
  • Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
    CANCER RESEARCH AND TREATMENT 49/1 :44-53,2017
  • Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer
    ANNALS OF SURGICAL ONCOLOGY 23/ :928-935,2016
  • Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY 46/10 :91-918,2016
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
    CANCER RESEARCH AND TREATMENT 48/4 :1,210-1,221,2016
  • Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
    BRITISH JOURNAL OF CANCER 115/1 :25-33,2016
  • A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 26/3 :168-176,2016
  • High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 142/9 :2051-2059,2016
  • Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
    PLOS ONE 11/8 :e0161475-,2016
  • Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: Implications for individualized therapy
    ONCOTARGET 7/28 :44608-44620,2016
  • A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis
    RADIOTHERAPY AND ONCOLOGY 118/2 :369-374,2016
  • p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
    CANCER RESEARCH AND TREATMENT 48/1 :208-215,2016
  • A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 93/5 :1015-1022,2015
  • Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
    CANCER RESEARCH AND TREATMENT 74/4 :781-789,2015
  • Clinical Implications from a Single-Center Study of Colorectal Adenocarcinoma in Transplant Recipients
    ONCOLOGY 88/4 :195-200,2015
  • Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases
    CANCER RESEARCH AND TREATMENT 47/2 :242-250,2015
  • Incorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal Cancer
    ANNALS OF SURGICAL ONCOLOGY 22/5 :1520-1526,2015
  • PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity
    INTERNATIONAL JOURNAL OF CANCER 136/10 :2273-2283,2015
  • Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
    CANCER RESEARCH AND TREATMENT 47/1 :9-17,2015
  • Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus
    ANTICANCER RESEARCH 34/4 :1939-1945,2014
  • High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
    WORLD JOURNAL OF SURGICAL ONCOLOGY 12/- :232-238,2014
  • Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    JOURNAL OF SURGICAL ONCOLOGY 110/2 :214-221,2014
  • A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer
    INVESTIGATIONAL NEW DRUGS 32/3 :561-568,2014
  • Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 140/3 :399-409,2014
  • Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE 231/ :21-28,2013
  • Quantitation and pharmacokinetics of 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio) butadiene (U0126) in rat plasma by liquid chromatography-tandem mass spectrometry
    JOURNAL OF SEPARATION SCIENCE 36/2 :239-245,2013
  • Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study
    ANNALS OF SURGICAL ONCOLOGY 20/11 :3407-3413,2013
  • Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 72/4 :853-860,2013
  • Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 72/ :825-835,2013
  • Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS 82/6 :504-513,2013
  • Changing treatment patterns in elderly patients with resectable colon cancer
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 9/3 :265-272,2013
  • Combination of CYP Inhibitor with MEK/ERK Inhibitor Enhances the Inhibitory Effect on ERK in BRAF Mutant Colon Cancer Cells
    ANTICANCER RESEARCH 33/6 :2499-2508,2013
  • Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
    SUPPORTIVE CARE IN CANCER 21/6 :1751-1759,2013
  • Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study
    JOURNAL OF SURGICAL ONCOLOGY 107/6 :613-618,2013
  • The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 27/1 :e53-e59,2013
  • Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent
    INVESTIGATIONAL NEW DRUGS 31/1 :1-13,2013
  • Quantitative Analysis of ERK Signaling Inhibition in Colon Cancer Cell Lines Using Phospho-Specific Flow Cytometry
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 34/ :309-316,2012
  • Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience
    BMC CANCER 12/1 :471-471,2012
  • Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer
    SURGICAL ONCOLOGY-OXFORD 21/3 :e125-e130,2012
  • Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea
    CLINICAL THERAPEUTICS 34/6 :1408-1419,2012
  • Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 69/1 :91-97,2012
  • VIPoma that arose from the rectum in a 65-year-old male patient
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 27/10 :1385-1386,2012
  • Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
    YONSEI MEDICAL JOURNAL 53/2 :352-357,2012
  • A phase i pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy
    INVESTIGATIONAL NEW DRUGS 30/4 :1501-1510,2012
  • Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer
    EUROPEAN RADIOLOGY 22/8 :1693-1700,2012
  • Response Evaluation in Patients With Colorectal Liver Metastases:RECIST Version 1.1 Versus Modified CT Criteria
    AMERICAN JOURNAL OF ROENTGENOLOGY 199/4 :809-815,2012
  • Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis
    Cancer Research and Treatment 44/1 :43-49,2012
  • Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging
    JOURNAL OF MAGNETIC RESONANCE IMAGING 35/3 :635-643,2012
  • A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy
    INVESTIGATIONAL NEW DRUGS 30/ :672-680,2012
  • Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
    BRITISH JOURNAL OF CANCER 106/1 :53-60,2012
  • DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer
    CANCER 117/9 :1847-1854,2011
  • Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis
    ONCOLOGY 81/3-4 :175-183,2011
  • Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81/3 :669-676,2011
  • Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity
    ONCOLOGY 80/1-2 :107-117,2011
  • Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 68/0 :991-999,2011
  • Comparison of Diffusion-Weighted MRI and MR Volumetry in the Evaluation of Early Treatment Outcomes After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
    JOURNAL OF MAGNETIC RESONANCE IMAGING 34/3 :570-576,2011
  • Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases
    RADIATION ONCOLOGY 6/0 :99-99,2011
  • Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
    INVESTIGATIONAL NEW DRUGS 29/5 :1073-1080,2011
  • Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles
    ONCOLOGY 80/5-6 :395-405,2011
  • Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer
    ANTI-CANCER DRUGS 22/8 :801-810,2011
  • A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy
    CANCER 117/10 :2050-2057,2011
  • Brain metastases from colorectal carcinoma: prognostic factors and outcome
    JOURNAL OF NEURO-ONCOLOGY 101/ :49-55,2011
  • A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
    Cancer Research and Treatment 42/4 :235-238,2010
  • The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
    RADIATION ONCOLOGY 5/ :75-75,2010
  • Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial
    Lung Cancer 70/1 :77-81,2010
  • A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer
    Investigational New Drugs 28/5 :650-658,2010
  • Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 136/3 :387-394,2010
  • Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer
    Radiotherapy And Oncology 95/3 :303-307,2010
  • A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer
    American Journal of Clinical Oncology-Cancer Clinical Trials 33/1 :56-60,2010
  • Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY 40/1 :29-35,2010
  • Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients
    Cancer Letters 288/1 :124-132,2010
  • Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction
    Yonsei Medical Journal 50/2 :296-299,2009
  • Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
    Journal Of Neuro-Oncology 91/3 :307-313,2009
  • Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in korea
    Cancer Research And Treatment 41/2 :67-72,2009
  • Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 65/1 :27-32,2009
  • Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer
    International Journal Of Oncology 34/3 :787-796,2009
  • Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 63/5 :919-927,2009
  • Mobilized CD34(+) cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer
    Cancer Letters 270/2 :269-276,2008
  • The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC
    Lung Cancer 60/3 :393-400,2008
  • Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
    Annals Of Oncology 19/6 :1135-1140,2008
  • Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy
    Cancer Chemotherapy And Pharmacology 61/ :309-313,2008
  • The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer
    Cancer Chemotherapy And Pharmacology 61/ :75-81,2008
  • Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer
    Cancer Chemotherapy And Pharmacology 61/ :157-165,2008
  • Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
    Radiotherapy And Oncology 87/ :361-366,2008
  • Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
    JOURNAL OF CLINICAL ONCOLOGY 25/18 :2528-2533,2007
  • Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy
    ACTA ONCOLOGICA 46/4 :547-549,2007
  • A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
    BRITISH JOURNAL OF CANCER 97/ :458-463,2007

신상준

진료철학
히포크라테스(BC 460~BC 377) 선서로 대변되는 생명의료윤리 철학은 이타적 서비스와 자율적 규제를 그 특성으로 하는 ‘의무론적 윤리’로서 오늘날 전문적 윤리(professional ethics)의 뿌리가 되었다. 의료(醫療)는 인간의 건강의 유지, 회복, 촉진 등에 대해서 사용되는 광범위한 의미를 가진 단어이다. 각 개인의 인생관에 따라서 가장 중요한 것의 차이는 있겠지만 의료는 인간을 대상으로 하고 생명을 직접적으로 다루는 분야이므로 의사의 의료철학은 중요하다고 생각되어지므로 환자를 보는데 내가 가지는 몇 가지 원칙을 밝히고자 한다.

첫째, 환자를 볼 때 가장 중요한 것은 ‘안타까움’이라고 생각한다. 기독교적 사랑을 바탕으로 환자의 고통에 대한 안타까움, 좀 더 나아지지 못함에 대한 안타까움이 좀 더 나은 기술, 좀 더 발전된 연구의 원동력이라고 생각한다.

둘째, 성실함이 중요하다. 의학은 평생을 함께하는 꾸준함이 필요하다. 아무리 뛰어난 재능과 자원, 풍부한 경험이 있더라도 환자에 대한 성실함이 부족하다면 환자와 보호자의 믿음을 이끌어내기 힘들고 치료효과도 기대하기 힘들 것이라고 생각된다.

셋째, 마지막으로 철저한 준비와 책임의식이다. 정확한 정보와 최신 지식을 얻기 위해 계속 정진하고 해결하지 못하는 문제점들을 정복하기 위한 지속적인 노력으로 환자를 위한 최선의 선택을 하는 것이 필요하다.

이 세 가지 원칙을 바탕으로 이타적 목적으로 바탕으로 환자의 이익에 최선을 다하는 종양내과 전문가이고자 합니다.

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보